Skip to Main Content

Author Details

Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
2005
23
15
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36993558Analysis of evolutionary dynamics and clonal architecture in prostate cancer.bioRxiv2023
38072760Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.Eur Urol Oncol2023
36103646Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.JCO Precis Oncol2022
35609992Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data.Genome Res2022
36177448A patient-driven clinicogenomic partnership for metastatic prostate cancer.Cell Genom2022
32852765Integrated Analysis of Germ Cell Tumors.Methods Mol Biol2021
33711272Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.Cancer Cell2021
33589424Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.Cancer Discov2021
34737445FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.Nat Cell Biol2021
34496240Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer.Cell Rep2021
33989011Metastatic Prostate Cancer: In Search of More Granularity.J Clin Oncol2021
28570732Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review.JAMA Oncol2018
23192356Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways.Prostate2013
24216509Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.J Clin Invest2013
23925295Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.J Clin Invest2013
23511791Novel chemotherapies in development for management of castration-resistant prostate cancer.Curr Opin Urol2013
22340590An animal model of MYC-driven medulloblastoma.Cancer Cell2012
23034120Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity.Genome Biol2012
22761590Extensive evolutionary changes in regulatory element activity during human origins are associated with altered gene expression and positive selection.PLoS Genet2012
19289629Genomic strategy for targeting therapy in castration-resistant prostate cancer.J Clin Oncol2009
19470786The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model.Cancer Prev Res (Phila)2009
18585849Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy.Eur Urol2008
16133915Osmolarity regulates gene expression in intervertebral disc cells determined by gene array and real-time quantitative RT-PCR.Ann Biomed Eng2005
  • 1 - 23 of 23

Recommended Authors

Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 4
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 7
Oncology R&D
Career Start Year 2013
Number of shared co-authors 9
University of British Columbia
Career Start Year 2011
Number of shared co-authors 4
University of California los angeles
Career Start Year 2011
Number of shared co-authors 4
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 8
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 17
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 8
University of British Columbia
Career Start Year 2008
Number of shared co-authors 1
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 6
University of British Columbia
Career Start Year 2007
Number of shared co-authors 7
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 7
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 11
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 9
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 7
University of Cambridge
Career Start Year 2003
Number of shared co-authors 0
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 12
University of British Columbia
Career Start Year 2002
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 12
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 8
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 12
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 3
University of British Columbia
Career Start Year 2000
Number of shared co-authors 3
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 7
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 6
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 9
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 15
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 10
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 16
University of Bern
Career Start Year 1990
Number of shared co-authors 16

Collaborators

Dana-Farber Cancer Institute
Co-authored papers 6
Illumina Inc.
Co-authored papers 5
Co-authored papers 4
Center for Genomic & Computational Biology, Duke University
Co-authored papers 3
Center for Genomic & Computational Biology, Duke University
Co-authored papers 3
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 3
University of Virginia
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
Co-authored papers 2
Center for Genomic and Computational Biology, Duke University.
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 1
University of Washington
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 1
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 1
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Center for Genomic and Computational Biology, Duke University Medical Center
Co-authored papers 1
Radboud university medical center
Co-authored papers 1
University of Washington
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
University of Illinois at Urbana-Champaign
Co-authored papers 1